Insights

Global Commercial Expansion Quibim recently appointed a Chief Business Officer to lead global commercial strategy and expand presence in life sciences, indicating openness to new partnerships, channel strategies, and cross-border deals with healthcare providers, research institutes, and pharma.

AI Imaging Platform The company focuses on AI-powered imaging biomarkers across MRI, CT, and PET, presenting opportunities to sell to hospitals, imaging centers, and CROs seeking quantitative biomarkers, workflow automation, and decision-support tools integration.

Strategic Partnerships Recent collaborations with Aidoc and NVIDIA MONAI, plus a Blackford Platform partnership, signal a market receptiveness to integrated AI ecosystems, offering a path to co-sell, bundle solutions, or embed Quibim capabilities within existing AI health platforms.

Financial Strength With a Series A of around €47.9-50M and a reported revenue range up to tens of millions, Quibim has funding runway and growth capital to support large deployments, enterprise pilots, and ongoing platform expansion into the US market.

Productively Positioned Recent product launches like AI-QUAL for automated PI-QUAL v2-compliant prostate MRI image quality assessment demonstrate a focus on regulatory-aligned, scalable modules that can be upsold as standalone features or integrated into existing imaging workflows for hospitals and imaging groups.

Similar companies to Quibim

Quibim Tech Stack

Quibim uses 8 technology products and services including MATLAB, Twitter Ads, WordPress, and more. Explore Quibim's tech stack below.

Media & News

Quibim's Email Address Formats

Quibim uses at least 4 email formats:
Quibim Email FormatsExamplePercentage
FirstLast@quibim.comJohnDoe@quibim.com
67%
First@quibim.comJohn@quibim.com
28%
FirstMiddleLast@quibim.comJohnMichaelDoe@quibim.com
3%
Middle@quibim.comMichael@quibim.com
2%

Frequently Asked Questions

What is Quibim's official website and social media links?

Minus sign iconPlus sign icon
Quibim's official website is quibim.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Quibim generate?

Minus sign iconPlus sign icon
As of October 2026, Quibim's annual revenue is estimated to be $1M - $10M.

What is Quibim's SIC code and NAICS code?

Minus sign iconPlus sign icon
Quibim's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Quibim have currently?

Minus sign iconPlus sign icon
As of October 2026, Quibim has approximately 116 employees across 3 continents, including Europe, North America and South America. Key team members include Chief People Officer: J. N. C., Chief Operating Officer: A. V. M. and Vice President Marketing & Communication: C. P. Explore Quibim's employee directory with LeadIQ.

What industry does Quibim belong to?

Minus sign iconPlus sign icon
Quibim operates in the Biotechnology Research industry.

What technology does Quibim use?

Minus sign iconPlus sign icon
Quibim's tech stack includes MATLAB, Twitter Ads, WordPress, Jenkins, MongoDB, Microsoft 365, Salesforce Marketing Cloud Account Engagement and Microsoft Azure.

What is Quibim's email format?

Minus sign iconPlus sign icon
Quibim's email format typically follows the pattern of FirstLast@quibim.com. Find more Quibim email formats with LeadIQ.

How much funding has Quibim raised to date?

Minus sign iconPlus sign icon
As of October 2026, Quibim has raised $70M in funding. The last funding round occurred on Jan 28, 2025 for $50M.

When was Quibim founded?

Minus sign iconPlus sign icon
Quibim was founded in 2015.
Quibim logo

Quibim

Biotechnology ResearchValencian Community, Spain51-200 Employees

Quibim is a biotechnology research company based in Valencia, Spain, that applies artificial intelligence to medical imaging to improve patient outcomes. It designs tools that extract information from MRI, CT, and PET images to generate data that can be transformed into actionable predictions for life sciences researchers and healthcare providers. The company markets imaging biomarkers for precision medicine and platforms such as QP-Prostate, and has introduced AI-QUAL, a feature that automates MRI image quality assessment for prostate imaging. Quibim has pursued partnerships and growth initiatives, including a January 2025 Series A financing and collaborations with Aidoc and NVIDIA MONAI. In 2026, Quibim expanded its leadership team with the appointment of Itta MacNevin as Chief Business Officer to support growth and broaden its commercial reach.

Section iconCompany Overview

Website
quibim.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $70M

    Quibim has raised a total of $70M of funding over 13 rounds. Their latest funding round was raised on Jan 28, 2025 in the amount of $50M as a Series A.

  • $1M - $10M

    Quibim's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.